Intuitive Surgical, Inc. (ISRG) PT Raised to $1,000.00
Intuitive Surgical, Inc. (NASDAQ:ISRG) had its target price hoisted by analysts at Barclays PLC to $1,000.00 in a research report issued on Friday, The Fly reports. The brokerage presently has an “overweight” rating on the medical equipment provider’s stock. Barclays PLC’s price target indicates a potential upside of 7.82% from the company’s previous close. The analysts noted that the move was a valuation call.
Several other research analysts also recently weighed in on ISRG. Canaccord Genuity reaffirmed a “buy” rating and issued a $800.00 target price on shares of Intuitive Surgical in a report on Friday, March 24th. Royal Bank Of Canada upped their target price on shares of Intuitive Surgical from $720.00 to $770.00 and gave the stock a “sector perform” rating in a report on Monday, April 17th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $860.00 target price for the company in a report on Tuesday, April 18th. Wedbush increased their price objective on shares of Intuitive Surgical from $800.00 to $835.00 and gave the company an “outperform” rating in a report on Wednesday, April 19th. Finally, Evercore ISI increased their price objective on shares of Intuitive Surgical from $750.00 to $785.00 and gave the company an “in-line” rating in a report on Wednesday, April 19th. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $953.97.
Intuitive Surgical (ISRG) traded down 4.55% during trading on Friday, hitting $927.47. The stock had a trading volume of 1,024,610 shares. The company has a 50-day moving average price of $934.93 and a 200-day moving average price of $803.42. The company has a market cap of $34.17 billion, a price-to-earnings ratio of 46.75 and a beta of 0.39. Intuitive Surgical has a 52-week low of $610.71 and a 52-week high of $974.66.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.79 by $0.16. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.51%. The firm had revenue of $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. During the same quarter in the previous year, the firm posted $5.62 EPS. The company’s revenue for the quarter was up 12.8% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical will post $23.59 EPS for the current year.
In related news, VP Jamie Samath sold 626 shares of the stock in a transaction dated Tuesday, April 25th. The shares were sold at an average price of $825.00, for a total value of $516,450.00. Following the sale, the vice president now directly owns 94 shares of the company’s stock, valued at approximately $77,550. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Marshall Mohr sold 8,950 shares of the stock in a transaction dated Thursday, April 27th. The stock was sold at an average price of $835.89, for a total transaction of $7,481,215.50. Following the completion of the sale, the chief financial officer now directly owns 6,422 shares in the company, valued at $5,368,085.58. The disclosure for this sale can be found here. Insiders sold a total of 28,041 shares of company stock worth $24,493,708 over the last three months. 2.50% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of ISRG. Guardian Life Insurance Co. of America raised its stake in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 3 shares during the period. Greenleaf Trust raised its stake in Intuitive Surgical by 0.8% in the first quarter. Greenleaf Trust now owns 477 shares of the medical equipment provider’s stock worth $366,000 after buying an additional 4 shares during the period. Dynamic Advisors Solutions LLC raised its stake in Intuitive Surgical by 0.6% in the first quarter. Dynamic Advisors Solutions LLC now owns 905 shares of the medical equipment provider’s stock worth $694,000 after buying an additional 5 shares during the period. Bronfman E.L. Rothschild L.P. raised its stake in Intuitive Surgical by 1.8% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 280 shares of the medical equipment provider’s stock worth $215,000 after buying an additional 5 shares during the period. Finally, Miles Capital Inc. raised its stake in Intuitive Surgical by 1.3% in the first quarter. Miles Capital Inc. now owns 566 shares of the medical equipment provider’s stock worth $434,000 after buying an additional 7 shares during the period. 97.53% of the stock is currently owned by institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.